The major limitation of nonhuman primate (NHP) embryonic stem (ES) cell research is inefficient genetic modification and limited knowledge of differentiation mechanisms. A genetically modified NHP-ES cell with biomarkers, such as green fluorescent protein (GFP), that allow noninvasive monitoring of transgenic cells, is a useful tool to study cell differentiation control during preimplantation and fetal development, which also plays a crucial role in the development of cell transplantation medicine. Here we report the establishment of transgenic NHP-ES cell lines that express GFP without jeopardizing their pluripotency, which was confirmed by in vitro and in vivo differentiation. These GFP-expressing ES cells reproducibly differentiated into embryoid bodies, neural cells, and cardiac myocytes. They formed teratoma composed of tissues derived from the three embryonic germ layers when transplanted into severe combined immunodeficient disease (SCID) mice. GFP expression was maintained in these differentiated cells, suggesting that these cells were useful for cell transplantation experiments. Furthermore, we showed that these ES cells have the ability to form chimeric blastocysts by introducing into the early preimplantation stage NHP embryo.
INTRODUCTION
entiation process. The capability to distinguish ES cells from the host cells allows accurate cell lineage analysis, Nonhuman primate (NHP) embryonic stem (ES) cells systematic monitoring of the tissue regeneration process, are considered to be one of the best models for studying and the validation of clinical application of cell transhuman development and the development of stem cell plantation. Here we report the establishment of eGFPtherapy for patients suffering from Parkinson's disease expressing NHP-ES cells preserving the pluripotency, (5) and diabetes mellitus (6), etc. (1, 2, 9, (12) (13) (14) 16) . The which is crucial for the advancement of stem cell techintroduction of disease-related genes and the capability nology and clinical applications. to replace specific genes using the gene targeting technique in NHP-ES cells without jeopardizing their pluri-MATERIALS AND METHODS potency is the key for the success of stem cell therapies.
ES Cell Culture However, the effect of the transfection procedure on pluripotency of NHP-ES cells is poorly understood. It
The cynomolgus monkey ES cell line (CMK5) was has been demonstrated that NHP-ES cells tend to differmaintained on a mitomycin C inactivated feeder layer entiate when dissociated into single cells (3, 9, (12) (13) (14) , of neomycin-resistant mouse embryonic fibroblasts in which limits the application of commonly used transfec-DMEM/F12 (1:1) medium containing 15% fetal bovine tion protocol. The establishment of a genetically modiserum (FBS; JRH, Lenexa, KS), 0.1 mM 2-mercaptoethfied NHP-ES cell line with a biomarker, enhanced green anol, and 1000 U/ml of leukemia inhibitory factor (LIF) fluorescent protein (eGFP), provides a powerful tool to (ESGRO) (Invitrogen, Carlsbad, CA) as described prestudy pluripotency in ES cells by monitoring the differviously (9).
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eGFP Expression Vector Construction ES colonies with strong eGFP expression were individually picked and transferred to 24-well plates with feed-The CMV-IE enhancer and human elongation factor ers. Then ES clones were propagated and used for dif-1α promoter (4) was excised from the GFP expression ferentiation analysis. vector (10) using HindIII and EcoRI site. It was then cloned into the HindIII-EcoRI digested pEGFP-1 vector
In Vitro Differentiation and Characterization (Clontech, Palo Alto, CA). This resulting plasmid was of Differentiated Cell Types linearized by HindIII-AlwNI digestion and used for elec-GFP-expressing ES cells were cultured in suspension troporation (11).
using bacteriological petri dishes with the ES medium Electroporation and Selection of ES Cells without 2-mercaptoethanol and LIF to form embryoid bodies (EBs). After 2-3 weeks of suspension culture, Twenty micrograms of linearized transgene was electroporated into a suspension of ES cells (1 × 10 7 ) in 1 the resulting EBs were transferred into the tissue culture dish to induce spontaneous differentiation in vitro. Dif-ml of PBS using a Bio-Rad gene pulser (500 µF, 250 V). Cells were then incubated on ice for 10 min, plated, ferentiated cells were characterized immunocytochemically using antibodies against human neurofilament and allowed to recover for 24 h before selection in medium containing G418 (200 µg/ml). Cells were fed daily, protein, glial fibrillary acidic protein (GFAP), and αmyosin heavy chain (α-MHC). and after 5 days of culture the resulting G418-resistant 
Teratoma Formation in SCID Mice
Detection of eGFP Expression Expression of eGFP was monitored by fluorescent Approximately 1 × 10 6 of eGFP-expressing ES cells were injected either intraperitoneally (IP) or subcutane-microscopy (IX-70 or SZX-12, Olympus, Japan) with a filter set for GFP (BP 470-490 and BA515). A handy ously (SC) into 8-week-old severe combined immunodeficient disease (SCID) mice (three male mice). Six UV light (365 nm) was used to observe the eGFP fluorescence of teratoma recovered from mice. weeks later, the resulting tumors were fixed in 4% paraformaldehyde, embedded in paraffin, and examined his-Immunohistochemical analysis was carried out in the sections prepared from teratoma using GFP monoclonal tologically after hematoxylin eosin staining. 
antibody (Clontech) and localized with Cy3-labeled goat
These EBs were then plated onto a tissue culture dish ( Fig. 1b) for further spontaneous differentiation. Elonga-anti-mouse immunoglobulin secondary antibody.
tion of processus was observed at 2-3 weeks after plat-ES Cell Injection Into Monkey ing. The presence of neurons ( Fig. 1c ) and astrocytes Preimplantation Embryos (data not shown) was identified by immunocytochemis-Cultured eGFP ES cells were dissociated with collatry (ICC) using antibodies against neurofilament progenase. eGFP-expressing ES cells were collected after teins and GFAP, respectively. In addition, we observed removal of the feeder cells by the attachment to the gelthe beating motion in some of the differentiated cells atinized culture dish at 37°C for 20 min. eGFP expresand further identified by ICC using antibody against husion was confirmed before and after aspirating ES cells man α-MHC, a marker for cardiac myocytes (Fig. 1d ). into the injection pipette. Zona pellucida was drilled Differentiation to cardiac myocytes was observed in apwith a piezo-driven injection pipette (PRIMtech, Ibaraki, proximately 1 of 10 EBs. This result suggested that the Japan) and two to four of the eGFP-expressing ES cells NHP-ES cell line was capable of differentiating to the were expelled into the perivitelline space of the fourcardiac lineage. Nevertheless, all EBs and differentiated cell stage cynomolgus monkey embryo. These injected cells expressed eGFP ubiquitously ( Fig. 1a, b, d ). embryos were cultured as described previously (15) .
For further confirmation of pluripotency, we grafted 1 × 10 6 of eGFP-expressing ES cells into SCID mice to RESULTS AND DISCUSSION investigate their differentiation potential in vivo. Six weeks after either IP or SC injection, teratoma formation Parental NHP-ES cells (CMK5) were cultured as reported previously (9) and electroporation was carried out was observed in all three mice ( Fig. 2a ). All teratomas and their cross sections showed green fluorescence un-using linearized expression vector of eGFP under the control of the human elongation factor 1α promoter and der the handy UV light (365 nm) ( Fig. 2b) , which indicated the expression of eGFP. Expression of eGFP was the CMV-IE enhancer (4,10,11). After G418 selection, eGFP-expressing ES cell colonies were picked mechan-also confirmed immunohistochemically using monoclonal antibody against GFP (Fig. 2c, d) . Histological ically and propagated. We established two cell lines (CMK5G-1, CMK5G-2) from two independent electro-examination suggested that these teratomas composed of tissues derived from the three embryonic germ layers, porations (one cell line per experiment) (Fig. 1a ). The normal karyotype (2n = 42) of eGFP-expressing ES cell ectoderm (neuron and glia), mesoderm (muscle, cartilage, bone), and endoderm (ciliated columnar epithe-lines was maintained in culture for more than 6 months in both cell lines. In addition, they remained undifferen-lium, gut epithelium) (data not shown). Basically similar results were obtained in both cell lines. tiated as indicated by the expression of alkaline phosphatase and stage-specific embryonic antigen-4 (data not
We further investigated the developmental potential of the eGFP-ES cells by producing a chimeric pre-shown), a commonly used marker for NHP-ES cells.
In vitro differentiation was conducted as reported by implantation embryo. We injected the eGFP-ES cells (CMKG-2) into four-cell stage preimplantation embryos Suemori et al. (9). After 1 week of suspension culture of CMK5G-1 in ES medium without 2-mercaptoethanol of cynomolgus monkeys and cultured in vitro (15) . Under this normal embryo culture condition, these ES cells and LIF, cystic embryoid bodies (EBs) were formed. (Fig. 3a, b) . 
